| Literature DB >> 32595880 |
Rommanee Rojasavastera1,2, Sunee Bovonsunthonchai1,2, Vimonwan Hiengkaew1, Vorapun Senanarong3.
Abstract
Owing to advancement of medical technology and current knowledge, the population has a longer life expectancy, leading to an increase in the proportion of elderly.Entities:
Keywords: action observation; cognition; gait; gait training; mild cognitive impairment
Year: 2020 PMID: 32595880 PMCID: PMC7304276 DOI: 10.1590/1980-57642020dn14-020004
Source DB: PubMed Journal: Dement Neuropsychol ISSN: 1980-5764
Figure 1Study protocol.
Training programs for action observation with gait training (AOGT) and gait training (GT) groups.
| Observation training (5 min) | Warm-up (5 min) | Gait training (40 min) | Cool-down (5 min) | Stretching (10 min) |
|---|---|---|---|---|
|
| 1) Swinging leg forward and backward | Sessions 1-3: Gait with markers and metronome 100 steps/min | 1) Swinging leg forward and backward | 1) Sitting on chair with legs extended and reaching toward toes |
Characteristics of participants in action observation with gait training (AOGT), gait training (GT) and control (CT) groups.
| Characteristics | AOGT (n=11) | GT (n=11) | CT (n=11) | p-value | |
|---|---|---|---|---|---|
| Age (years)[ | 67.64±4.64 | 67.50±5.60 | 65.71±2.45 | 0.530 | |
| Sex (Male:Female)[ | 2:9 | 3:8 | 3:8 | 0.852 | |
| Education (years)[ | 13.50±3.25 | 13.82±4.35 | 12.73±4.43 | 0.811 | |
| Body Mass Index (kg/m2)[ | 24.08±3.19 | 24.71±3.69 | 25.38±3.80 | 0.697 | |
| Underlying disease[ | Diabetes Mellitus | 0 | 4 | 1 | 0.051 |
| Hypertension | 6 | 5 | 5 | 0.889 | |
| Hyperlipidemia | 4 | 2 | 3 | 0.641 | |
| Lifestyle (active:sedentary)[ | 5:6 | 6:5 | 7:4 | 0.701 | |
| PHQ-9 (score)[ | 2.82±2.82 | 2.27±2.45 | 1.91±1.92 | 0.680 | |
| Short FES-I (score)[ | 11.27±5.52 | 11.36±3.72 | 8.82±1.40 | 0.242 | |
| Sensation in LE (intact)[ | 11 | 11 | 11 | 1.000 | |
| Chair stand test (number)[ | 14.82±4.94 | 14.82±2.93 | 16.00±4.29 | 0.744 | |
| Single-leg stand test (s)[ | Eyes open | 38.67±22.72 | 39.05±21.23 | 44.93±21.09 | 0.752 |
| Eyes closed | 6.70±6.84 | 4.73±4.38 | 9.69±12.88 | 0.422 | |
| Duration for 12 sessions of training (week)[ | 4.91±0.83 | 4.55±0.82 | - | 0.314 | |
| Borg scale after gait training phase (score)[ | 11.55±2.42 | 11.64±2.11 | - | 0.926 | |
LE: lower extremities; PHQ-9: Patient Health Questionnaire-9; Short FES-I: shortened version of falls efficacy scale. Data expressed as mean±standard deviation or number.
Significant difference tested by one-way ANOVA for p<0.05;
Significant difference tested by Kruskal-Wallis H test for p<0.05;
Significant difference tested by independent t-test for p<0.05.
Within-group and pairwise comparison of variables assessed.
| Variables | T1 (mean±SD) | T2 (mean±SD) | T3 (mean±SD) | df (time) | df (error) | F value | p-value[ | p-value[ | p-value[ | p-value[ |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| AOGT | 0.86±0.16 | 1.02±0.15 | 1.01±0.15 | 2 | 20 | 25.843 | <0.001 | <0.001 | <0.001 | 0.252 |
| GT | 0.94±0.14 | 1.03±0.10 | 1.06±0.10 | 1.305 | 0.065 | 9.424 | 0.006 | 0.038 | <0.001 | 0.223 |
| CT | 0.88±0.15 | 0.88±0.15 | 0.87±0.17 | 2 | 20 | 0.235 | 0.793 | - | - | - |
|
| ||||||||||
| AOGT | 0.69±0.17 | 0.86±0.22 | 0.84±0.23 | 2 | 20 | 32.638 | <0.001 | <0.001 | <0.001 | 0.393 |
| GT | 0.70±0.24 | 0.82±0.24 | 0.82±0.23 | 2 | 20 | 8.836 | 0.002 | 0.009 | 0.009 | 0.940 |
| CT | 0.64±0.18 | 0.62±0.19 | 0.68±0.18 | 2 | 20 | 2.394 | 0.117 | - | - | - |
|
| ||||||||||
| AOGT | 2.42±1.15 | 2.48±0.73 | 2.33±0.89 | 2 | 20 | 0.065 | 0.937 | - | - | - |
| GT | 1.85±0.78 | 1.86±0.71 | 1.80±0.72 | 2 | 20 | 0.030 | 0.970 | - | - | - |
| CT | 2.67±0.98 | 2.87±1.21 | 2.33±1.12 | 1.335 | 13.354 | 1.553 | 0.242 | - | - | - |
|
| ||||||||||
| AOGT | 5.30±3.90 | 3.89±2.29 | 3.73±2.06 | 2 | 20 | 2.944 | 0.076 | - | - | - |
| GT | 5.34±4.93 | 4.95±5.95 | 4.19±4.85 | 2 | 20 | 1.685 | 0.211 | - | - | - |
| CT | 5.41±2.63 | 6.34±4.40 | 6.61±3.74 | 2 | 20 | 0.572 | 0.573 | - | - | - |
|
| ||||||||||
| AOGT | 1.94±0.41 | 1.81±0.54 | 1.64±0.52 | 2 | 20 | 4.824 | 0.020 | 0.225 | 0.017 | 0.060 |
| GT | 1.65±0.50 | 1.75±0.55 | 1.85±0.61 | 2 | 20 | 0.461 | 0.637 | - | - | - |
| CT | 2.18±0.88 | 2.15±0.91 | 1.87±0.51 | 2 | 20 | 0.901 | 0.422 | - | - | - |
|
| ||||||||||
| AOGT | 2.72±1.79 | 2.20±0.81 | 2.01±0.79 | 1.313 | 13.128 | 2.332 | 0.147 | - | - | - |
| GT | 2.92±1.25 | 2.31±0.72 | 2.45±0.93 | 2 | 20 | 2.429 | 0.114 | - | - | - |
| CT | 2.90±0.88 | 3.33±1.35 | 3.28±1.15 | 2 | 20 | 0.769 | 0.477 | - | - | - |
|
| ||||||||||
| AOGT | 22.18±1.47 | 24.64±2.34 | 26.82±2.04 | 2 | 20 | 30.373 | <0.001 | 0.001 | <0.001 | 0.012 |
| GT | 22.64±1.36 | 24.00±2.86 | 25.00±3.16 | 2 | 20 | 4.280 | 0.028 | 0.124 | 0.019 | 0.226 |
| CT | 22.18±1.94 | 24.45±2.91 | 24.54±2.91 | 2 | 20 | 8.727 | 0.002 | 0.003 | 0.007 | 0.892 |
AOGT: Action observation with gait training; GT: gait training; CT: control; T1: baseline; T2: after training; T3: at 1-month follow-up;
p-values tested by repeated measure ANOVA;
p-values tested by LSD post-hoc analysis; p-values in bold represent significant differences.
Between-group and pairwise comparison of variables assessed.
| Variables | AOGT (mean±SD) | GT (mean±SD) | CT (mean±SD) | df (Between Groups) | df (Within Groups) | F value | p-value[ | p-value[ | p-value[ | p-value[ |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| T2-T1 | 0.17±0.10 | 0.09±0.12 | 0.00±0.08 | 2 | 30 | 7.084 | 0.003 | 0.085 | 0.001 | 0.057 |
| T3-T1 | 0.15±0.09 | 0.12±0.08 | -0.01±0.10 | 2 | 30 | 10.613 | <0.001 | 0.399 | <0.001 | 0.002 |
|
| ||||||||||
| T2-T1 | 0.17±0.07 | 0.12±0.13 | -0.02±0.07 | 2 | 30 | 12.770 | <0.001 | 0.248 | <0.001 | 0.001 |
| T3-T1 | 0.15±0.08 | 0.12±0.13 | 0.04±0.10 | 2 | 30 | 3.619 | 0.039 | 0.520 | 0.015 | 0.063 |
|
| ||||||||||
| T2-T1 | 0.06±1.49 | 0.01±0.89 | 0.20±0.95 | 2 | 30 | 0.079 | 0.924 | - | - | - |
| T3-T1 | -0.09±1.73 | -0.05±1.19 | -0.34±0.69 | 2 | 30 | 0.158 | 0.855 | - | - | - |
|
| ||||||||||
| T2-T1 | -1.41±2.50 | -0.38±2.63 | 0.93±3.18 | 2 | 30 | 1.941 | 0.161 | - | - | - |
| T3-T1 | -1.57±2.76 | -1.15±1.90 | 1.20±3.55 | 2 | 30 | 3.077 | 0.061 | - | - | - |
|
| ||||||||||
| T2-T1 | -0.14±0.35 | 0.10±0.51 | -0.03±0.84 | 2 | 30 | 0.427 | 0.657 | - | - | - |
| T3-T1 | -0.30±0.35 | 0.20±0.75 | -0.31±0.91 | 2 | 30 | 1.861 | 0.173 | - | - | - |
|
| ||||||||||
| T2-T1 | -0.52±1.23 | -0.61±0.99 | 0.43±1.05 | 2 | 30 | 3.020 | 0.064 | - | - | - |
| T3-T1 | -0.70±1.38 | -0.46±0.91 | 0.38±1.16 | 2 | 30 | 2.624 | 0.089 | - | - | - |
|
| ||||||||||
| T2-T1 | 2.45±1.63 | 1.36±2.69 | 2.27±1.90 | 2 | 30 | 0.832 | 0.445 | - | - | - |
| T3-T1 | 4.64±1.86 | 2.36±2.80 | 2.36±2.29 | 2 | 30 | 3.430 | 0.046 | 0.031 | 0.031 | 1.000 |
AOGT: Action observation with gait training; GT: gait training; CT: control; T1: baseline; T2: after training; T3: at 1-month follow-up;
p-values tested by one way ANOVA;
p-values tested by LSD post-hoc analysis; p-values in bold represent significant differences.